Use of Virostatics as a Means of Targeting Human Immunodeficiency Virus Infection

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|9|1121-1127

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.9, 2006-03, pp. : 1121-1127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting frameshifting in the human immunodeficiency virus

By Brakier-Gingras Léa   Charbonneau Johanie   Butcher Samuel E  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 3, 2012-03 ,pp. : 249-258

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Assembly of the Human Immunodeficiency Virus Type I

By  

Current Pharmaceutical Design, Vol. 10, Iss. 30, 2004-11 ,pp. : 3725-3739

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Strategies for Human Immunodeficiency Virus: A Combinatorial Approach

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 3, 2012-03 ,pp. : 236-254

Bentham Science Publishers

Access to resources Recommend Favorite

Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection

By Kaplan Susan S   Hicks Charles B  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1573-1585

Informa Healthcare

Access to resources Recommend Favorite

Neurotransmitter Effects in Human Immunodeficiency Virus (HIV) and Simian Immuno-Deficiency Virus (SIV) Infection

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 8, Iss. 2, 2009-06 ,pp. : 153-163

Bentham Science Publishers

Access to resources Recommend Favorite